May 14 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Merck's MRK.N cancer drug to expand its use to two types adrenal gland tumors.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar)
((Puyaan.Singh@thomsonreuters.com;))